Robert Sidonio on the Role of aPCC in Patients Receiving Emicizumab Prophylaxis
Robert Sidonio, Professor of Pediatrics at Emory University Hospital, shared a post on LinkedIn:
”It is our great pleasure to share that our publication “Activated Prothrombin Complex Concentrate in Patients Receiving Emicizumab Prophylaxis: From Evidence to Clinical Practice” is now available for free access online as Pre-proof. Thanks to Takeda for organizing this awesome group of hematologists!”
Read the full article here.
In the recently published article ‘Activated Prothrombin Complex Concentrate in Patients Receiving Emicizumab Prophylaxis: From Evidence to Clinical Practice‘ by Robert F. Sidonio Jr. et al., in the RPTH Journal, the role of Activated Prothrombin Complex Concentrate in patients receiving Emicizumab prophyaxis is discussed.
Stay updated on the latest scientific advancements in the filed with Hemostasis Today.
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH